title: Diagnosis and treatment of familial hypercholesterolemia: The impact of recent guidelines.
abstract: Treatment of familial hypercholesterolemia can change the natural course of the disease to prevent premature atherosclerotic cardiovascular disease. New guidelines assist the clinician in the early identification of this common genetic disorder of lipid metabolism by placing individuals with elevated low-density lipoprotein cholesterol levels in high-risk groups who benefit from treatment with statins.
authors.affiliation: Lynne Palma is an NP and program coordinator at Florida Atlantic University, Boca Raton, Fla. Marguerite Welding is an NP at George Azar, MD, Ft. Lauderdale, Fla. Jennifer O'Shea is a clinical pharmacist at United Healthcare, Miramar, Fla.
authors.forename: Lynne
authors.initials: L
authors.lastname: Palma
authors.forename: Marguerite
authors.initials: M
authors.lastname: Welding
authors.forename: Jennifer
authors.initials: J
authors.lastname: OʼShea
mesh_terms: D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D018570:Risk Assessment
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors